Conditions:
Start date: May 2025
Location: Canada (Remote)
Interviews: Scheduled immediately
Language: English, additional Languages are a plus
Project: CNS, Rare Disease
Key Responsibilities:
Develop and execute global medical strategies for Phase III programs, ensuring alignment with corporate objectives, clinical development, and lifecycle management goals.
Build and maintain strong relationships with KOLs, clinical investigators, and healthcare professionals to support scientific and medical objectives.
Lead medical affairs activities, including data dissemination, publication planning, and regulatory submissions, ensuring compliance with international frameworks.
Act as the medical lead within cross-functional teams, supporting clinical trial design, market access, and commercial strategies.
Provide scientific and clinical insights, interpret complex data, and champion innovative, patient-centric approaches to address unmet medical needs.
Requirements
Extensive expertise in late-stage drug development, lifecycle management, and Canadian regulatory frameworks.
Demonstrated success in managing KOLs and fostering strong relationships with clinicians and healthcare professionals.
A strategic mindset capable of integrating local and global medical strategies.
Outstanding leadership skills with a proven ability to collaborate across functions.
Superior communication and presentation skills.
Deep scientific and clinical knowledge, with proficiency in analyzing and interpreting complex data.
Adaptable to fast-paced, dynamic environments with a strong commitment to innovation and patient-centric outcomes.
If this role is of interest to you, please apply directly to learn more about the role. If not feel free to share with your network.
